123 related articles for article (PubMed ID: 8145227)
1. Comparative molecular field analysis of the antitumor activity of 9H-thioxanthen-9-one derivatives against pancreatic ductal carcinoma 03.
Horwitz JP; Massova I; Wiese TE; Besler BH; Corbett TH
J Med Chem; 1994 Mar; 37(6):781-6. PubMed ID: 8145227
[TBL] [Abstract][Full Text] [Related]
2. Comparative molecular field analysis of in vitro growth inhibition of L1210 and HCT-8 cells by some pyrazoloacridines.
Horwitz JP; Massova I; Wiese TE; Wozniak AJ; Corbett TH; Sebolt-Leopold JS; Capps DB; Leopold WR
J Med Chem; 1993 Nov; 36(23):3511-6. PubMed ID: 8280289
[TBL] [Abstract][Full Text] [Related]
3. A comparative molecular field analysis (CoMFA) study using semiempirical, density functional, ab initio methods and pharmacophore derivation using DISCOtech on sigma 1 ligands.
Jung D; Floyd J; Gund TM
J Comput Chem; 2004 Aug; 25(11):1385-99. PubMed ID: 15185333
[TBL] [Abstract][Full Text] [Related]
4. Different electrostatic descriptors in comparative molecular field analysis: A comparison of molecular electrostatic and coulomb potentials.
Kroemer RT; Hecht P; Liedl KR
J Comput Chem; 1996 Aug; 17(11):1296-308. PubMed ID: 25400148
[TBL] [Abstract][Full Text] [Related]
5. Three-dimensional quantitative structure-activity relationship of angiotesin-converting enzyme and thermolysin inhibitors. II. A comparison of CoMFA models incorporating molecular orbital fields and desolvation free energies based on active-analog and complementary-receptor-field alignment rules.
Waller CL; Marshall GR
J Med Chem; 1993 Aug; 36(16):2390-403. PubMed ID: 8360884
[TBL] [Abstract][Full Text] [Related]
6. Three-dimensional quantitative structure-activity relationship of interleukin 1-beta converting enzyme inhibitors: A comparative molecular field analysis study.
Kulkarni SS; Kulkarni VM
J Med Chem; 1999 Feb; 42(3):373-80. PubMed ID: 9986707
[TBL] [Abstract][Full Text] [Related]
7. The use of atomic charges and orbital energies as hydrogen-bonding-donor parameters for QSAR studies: comparison of MNDO, AM1 and PM3 methods.
Ghafourian T; Dearden JC
J Pharm Pharmacol; 2000 Jun; 52(6):603-10. PubMed ID: 10875535
[TBL] [Abstract][Full Text] [Related]
8. Partial charge calculation method affects CoMFA QSAR prediction accuracy.
Mittal RR; Harris L; McKinnon RA; Sorich MJ
J Chem Inf Model; 2009 Mar; 49(3):704-9. PubMed ID: 19239274
[TBL] [Abstract][Full Text] [Related]
9. Molecular modeling of phenothiazines and related drugs as multidrug resistance modifiers: a comparative molecular field analysis study.
Pajeva I; Wiese M
J Med Chem; 1998 May; 41(11):1815-26. PubMed ID: 9599232
[TBL] [Abstract][Full Text] [Related]
10. Comparative molecular field analysis of artemisinin derivatives: ab initio versus semiempirical optimized structures.
Tonmunphean S; Kokpol S; Parasuk V; Wolschann P; Winger RH; Liedl KR; Rode BM
J Comput Aided Mol Des; 1998 Jul; 12(4):397-409. PubMed ID: 9777497
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, cytotoxic activity, NMR study and stereochemical effects of some new pyrano[3,2-b]thioxanthen-6-ones and pyrano[2,3-c]thioxanthen-7-ones.
Kostakis IK; Pouli N; Marakos P; Mikros E; Skaltsounis AL; Leonce S; Atassi G; Renard P
Bioorg Med Chem; 2001 Nov; 9(11):2793-802. PubMed ID: 11597459
[TBL] [Abstract][Full Text] [Related]
12. Ligand-based CoMFA and CoMSIA studies on chromone derivatives as radical scavengers.
Phosrithong N; Ungwitayatorn J
Bioorg Chem; 2013 Aug; 49():9-15. PubMed ID: 23838011
[TBL] [Abstract][Full Text] [Related]
13. 3D-QSAR of human immunodeficiency virus (I) protease inhibitors. III. Interpretation of CoMFA results.
Opera TI; Waller CL; Marshall GR
Drug Des Discov; 1994 Jul; 12(1):29-51. PubMed ID: 7578806
[TBL] [Abstract][Full Text] [Related]
14. Theoretical investigations on the molecular structure, vibrational spectral, HOMO-LUMO and NBO analysis of 9-[3-(Dimethylamino)propyl]-2-trifluoro-methyl-9H-thioxanthen-9-ol.
Mary YS; Panicker CY; Yamuna TS; Siddegowda MS; Yathirajan HS; Al-Saadi AA; Van Alsenoy C
Spectrochim Acta A Mol Biomol Spectrosc; 2014 Nov; 132():491-501. PubMed ID: 24892527
[TBL] [Abstract][Full Text] [Related]
15. Comparative molecular field analysis and molecular modeling studies of 20-(S)-camptothecin analogs as inhibitors of DNA topoisomerase I and anticancer/antitumor agents.
Carrigan SW; Fox PC; Wall ME; Wani MC; Bowen JP
J Comput Aided Mol Des; 1997 Jan; 11(1):71-8. PubMed ID: 9139114
[TBL] [Abstract][Full Text] [Related]
16. 3D-QSAR CoMFA/CoMSIA studies on 5-aryl-2,2-dialkyl-4-phenyl-3(2H)-furanone derivatives, as selective COX-2 inhibitors.
Puntambekar DS; Giridhar R; Yadav MR
Acta Pharm; 2006 Jun; 56(2):157-74. PubMed ID: 16613723
[TBL] [Abstract][Full Text] [Related]
17. Analogues of hycanthone and lucanthone as antitumor agents.
Archer S; Zayed AH; Rej R; Rugino TA
J Med Chem; 1983 Sep; 26(9):1240-6. PubMed ID: 6887199
[TBL] [Abstract][Full Text] [Related]
18. CoMFA-based prediction of agonist affinities at recombinant D1 vs D2 dopamine receptors.
Wilcox RE; Tseng T; Brusniak MY; Ginsburg B; Pearlman RS; Teeter M; DuRand C; Starr S; Neve KA
J Med Chem; 1998 Oct; 41(22):4385-99. PubMed ID: 9784114
[TBL] [Abstract][Full Text] [Related]
19. A structure-based analysis of the vibrational spectra of nitrosyl ligands in transition-metal coordination complexes and clusters.
De La Cruz C; Sheppard N
Spectrochim Acta A Mol Biomol Spectrosc; 2011 Jan; 78(1):7-28. PubMed ID: 21123107
[TBL] [Abstract][Full Text] [Related]
20. Understanding the antitumor activity of novel tricyclicpiperazinyl derivatives as farnesyltransferase inhibitors using CoMFA and CoMSIA.
Puntambekar DS; Giridhar R; Yadav MR
Eur J Med Chem; 2006 Nov; 41(11):1279-92. PubMed ID: 16919851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
